Brought to you by 
Elan acquires Sano in a $375mm all-stock transaction
13 Jul 1999
Executive Summary
Drug delivery biopharmaceutical Elan will acquire Sano, a transdermal delivery company, in a tax-free, all-stock transaction for about $375mm, or $35.50 per share (a (pr)35% premium to the $23 share price the day before the announcement).
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Elan acquires Sano in a $375mm all-stock transaction
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice